CD36 and breast cancer: Analysis of The Cancer Genome Atlas (TCGA) showed that AKR1C1, AQP7, CD36, and LIPE display low genomic alteration frequency in breast cancer, and only CD36 expression has prognostic value (P = 0.005) (Supplementary Fig. 6a–c).